NPR's Melissa Block talks to Dr. Kenneth Offit, chief of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center, about a new study published in the Journal of the American Medical Association. The study addresses the effectiveness of prophylactic surgery for people with the BRCA1 or BRCA2 genes.